EUVIMEDEUVIMED entdecken
Crossref

The Prognostic Value of Three-Dimensional Speckle-Tracking Echocardiography−Derived Right Ventricular Function in Light-Chain Cardiac Amyloidosis

Fangmin Meng, Jing Li, Rui Zhao, Shihai Zhao, Yingying Jiang, Yuanfeng Wu, Y U Liu, Yiming Yang, Yang Yang, Nianwei Zhou, Lili Dong, Dehong Kong und 4 weitere

Journal of Cardiac Failure · 2026-05 · 32 (5) · 824-836

DOI: 10.1016/j.cardfail.2026.02.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiac Failure, 2026-05. Verfasst von Fangmin Meng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai, China; Shanghai Institute of Medical Imaging, Shanghai, China. Hauptthemen laut MEDLINE: Echocardiography, Three-Dimensional, Ventricular Function, Right, Ventricular Dysfunction, Right, Immunoglobulin Light-chain Amyloidosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Right ventricular (RV) dysfunction is a key prognostic factor in light-chain cardiac amyloidosis (AL-CA). Although 2-dimensional speckle tracking echocardiography has demonstrated predictive value, 3-dimensional speckle tracking echocardiography (3D-STE) allows for a more comprehensive assessment of RV function. However, data on 3D-STE-based RV evaluation in AL-CA remain limited. This study aimed to assess the prognostic value of RV parameters derived from 3D-STE and their contribution to improving mortality risk prediction. METHODS: This prospective study enrolled newly diagnosed patients with biopsy-confirmed AL-CA between 2022 and 2025. Each participant received a comprehensive echocardiography study before the initiation of standard chemotherapy. 3D-STE RV parameters were quantified using dedicated software (4D RV-Function 3; Philips Healthcare). The primary study endpoint was all-cause mortality. RESULTS: A total of 142 patients (mean age: 63.1 ± 9.5 years; 71.1% male) were included, with 52 (36.6%) reaching the primary endpoint. The median follow-up was 205 days (interquartile range, 208 days). Nonsurvivors exhibited significantly worse biventricular function. In multivariable Cox analysis, 3D RVEF (hazard ratio, 0.94, P < .001) was a powerful independent predictor of mortality after adjustment for sex, age, Mayo 2012 stage, left ventricular global longitudinal strain, and pulmonary arterial systolic pressure. Kaplan-Meier analysis confirmed that a 3D RVEF threshold of 40% identified a high-risk group with significantly worse survival (log-rank, P < .001); this cutoff was consistently prognostic across all disease stages and treatment subgroups. The addition of 3D RVEF to the baseline LVGLS model provided the greatest incremental prognostic value among all RV parameters (C-index increase from 0.804 to 0.828; likelihood ratio χ² = 78.65, P < .001). CONCLUSIONS: 3D-STE-derived RVEF is a strong, independent predictor of mortality in AL-CA. A cut-off value of 40% effectively stratifies risk and significantly optimizes prognostic models beyond standard LV metrics. Routine assessment of 3D RV function could enhance risk stratification and guide disease management of patients with AL-CA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Echocardiography, Three-DimensionalVentricular Function, RightVentricular Dysfunction, RightImmunoglobulin Light-chain AmyloidosisCardiomyopathiesHumansPrognosisFemaleProspective StudiesMaleMiddle AgedAgedGlobal Longitudinal StrainFollow-Up Studies

Stichwörter der Autor:innen

Cardiac amyloidosislight-chain amyloidosisprognosisright ventricular dysfunction

Autor:innen und Institutionen

  • Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai, China; Shanghai Institute of Medical Imaging, Shanghai, China.
  • Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
  • Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Shanghai Me…

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Meng, F., Li, J., Zhao, R., Zhao, S., Jiang, Y., Wu, Y., Liu, Y. U., Yang, Y., Yang, Y., Zhou, N., Dong, L., Kong, D., Chen, H., Shu, X., Liu, P., & Pan, C. (2026). The Prognostic Value of Three-Dimensional Speckle-Tracking Echocardiography−Derived Right Ventricular Function in Light-Chain Cardiac Amyloidosis. Journal of Cardiac Failure, 32(5), 824-836. https://doi.org/10.1016/j.cardfail.2026.02.010

Vancouver

Meng F, Li J, Zhao R, Zhao S, Jiang Y, Wu Y, et al. The Prognostic Value of Three-Dimensional Speckle-Tracking Echocardiography−Derived Right Ventricular Function in Light-Chain Cardiac Amyloidosis. Journal of Cardiac Failure. 2026;32(5):824-836. doi:10.1016/j.cardfail.2026.02.010

BibTeX
@article{Meng2026,
  author = {Meng, Fangmin and Li, Jing and Zhao, Rui and Zhao, Shihai and Jiang, Yingying and Wu, Yuanfeng and Liu, Y U and Yang, Yiming and Yang, Yang and Zhou, Nianwei and Dong, Lili and Kong, Dehong and Chen, Haiyan and Shu, Xianhong and Liu, Peng and Pan, Cuizhen},
  title = {The Prognostic Value of Three-Dimensional Speckle-Tracking Echocardiography−Derived Right Ventricular Function in Light-Chain Cardiac Amyloidosis},
  journal = {Journal of Cardiac Failure},
  year = {2026},
  volume = {32},
  number = {5},
  pages = {824--836},
  doi = {10.1016/j.cardfail.2026.02.010}
}
Kostenlos starten →